EXPORT CITATION

Chapter-59 Association between Use of Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors with All-cause Mortality in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis

BOOK TITLE: Year Book of Medicine 2019

Author
1. Shah Siddharth N
2. Mittal Naveen
3. Rohatgi Ragini M
ISBN
9789389188738
DOI
10.5005/jp/books/18366_61
Edition
1/e
Publishing Year
2019
Pages
2
Author Affiliations
1. University of Mumbai, Consulting Physician and Diabetologist, SL Raheja Hospital and All India Institute of Diabetes, Saifee Hospital, Bhatia Hospital, Sir Hurkisondas, N Hospital, Mumbai, Maharashtra, India, University of Mumbai, Consulting Physician and Diabetologist, SL Raheja Hospital and All India Institute, of Diabetes, Saifee Hospital, Bhatia Hospital, Sir Hurkisondas, N Hospital, Mumbai, Maharashtra, India, Bhatia Hospitals, Mumbai, Maharashtra, India, S. L. Raheja Hospital, Bhatia Hospital, and Sir H. N. Hospital, Mumbai, SL Raheja Hospital, Mumbai, Maharashtra, India, Bhatia Hospital, Saifee Hospital; Journal of Association of Physicians of India; API Textbook of Medicine, IX Edition, Mumbai, Maharashtra, India, Mumbai, Maharashtra, India, Bhatia Hospital, Mumbai, Maharashtra, India, Sir HN Reliance Hospital, Bhatia Hospital, SL Raheja Hospital, Saifee Hospital, Global Hospital, Mumbai, Maharashtra, India; JAPI, API Textbook of Medicine, Xth Edition, University of Mumbai; Bhatia, SL Raheja; Saifee,
2. Dayanand Medical College and Hospital, Ludhiana, Punjab, India
3. Rohit Diabetes Centre, Jeevan Vikas Kendra Hospital, Mumbai, Maharashtra, India
Chapter keywords
Sodium-glucose cotransporter-2 inhibitor, glucagon-like peptide 1 agonist, dipeptidyl peptidase 4 inhibitor, type 2 diabetes, meta-analysis, cardiovascular disease, heart failure, HF, myocardial infarction

Abstract

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved